Craig Mayer, Nick WIlliams, Vojtech Huser
Lister Hill National Center for Biomedical Communications, National Library of Medicine, NIH, Bethesda, MD

See the full regCTG repository at https://github.com/lhncbc/CRI/tree/master/regCTG

To return to the list of conditions and view other reports go to https://lhncbc.github.io/CRI/regCTG/regCTG-condition_report_links.html

Study Counts

Type Study_count
Total_Studies 117
interventional 83
Observational 29
Registry 5

Studies over Time by Start Date

```

Interventional Trials

Intervention Type

intervention_type Study_Count
Drug 33
Drug|placebo 18
Other 6
Device 5
Biological 4
Behavioral 3
Biological|placebo 3
Device|placebo 2
Diagnostic Test 2
Drug|Other 2
Biological|Drug|Other|Procedure 1
Device|Other 1
Device|Procedure 1
Other|Procedure 1
Procedure 1

Count of Studies by Intervention (normalized and mapped)

Interventions over Time

Yearly studies for each intervention by start date

Studies by Country

Country Study_Count
United States 17
Denmark 6
NA 6
France 5
Germany 3
Mexico 3
Netherlands 3
Canada 2
Japan 2
United States|Canada 2
United States|Mexico 2
Argentina|Brazil|France|Germany|Portugal|Sweden 1
Armenia|Austria|Belarus|Belgium|Bulgaria|Czechia|Finland|France|Germany|Greece|Hungary|Italy|Poland|Portugal|Romania|Russian Federation|Slovakia|Slovenia|Spain|Sweden|Turkey|United Kingdom 1
Belgium|Finland|France|Germany|Poland 1
Belgium|France 1
Brazil 1
Brazil|France 1
Egypt 1
France|Germany|Portugal|Spain|Sweden|United Kingdom 1
Germany|Bulgaria|Romania 1
Germany|United Kingdom 1
India 1
Israel|Russian Federation 1
Italy 1
Italy|United States|Argentina|Canada|Czech Republic|Germany|Israel|Mexico|Poland|Serbia 1
Philippines 1
Spain 1
Sweden 1
Switzerland 1
Thailand 1
Turkey 1
United States|Argentina|Australia|Brazil|Bulgaria|Canada|Cyprus|France|Germany|Italy|Japan|Korea, Republic of|Malaysia|Mexico|Netherlands|Portugal|Spain|Sweden|Taiwan|Turkey|United Kingdom 1
United States|Argentina|Brazil|France|Germany|Italy|New Zealand|Portugal|Spain|United Kingdom 1
United States|Argentina|Brazil|France|Germany|Italy|Portugal|Spain|United Kingdom 1
United States|Argentina|Brazil|France|Germany|Portugal|Spain|Sweden|United Kingdom 1
United States|Australia|Belgium|Canada|Czechia|Estonia|Finland|France|Germany|Israel|Italy|Japan|Netherlands|Poland|Spain|United Kingdom 1
United States|Australia|Canada|Czechia|France|Germany|Italy|Japan|Netherlands|Spain|United Kingdom 1
United States|Canada|France|Germany|Italy|Mexico|Puerto Rico 1
United States|Croatia|Denmark|France|Italy|Netherlands|Spain|Sweden|United Kingdom 1
United States|France|Germany|Italy 1
United States|Georgia|Israel|Latvia|Poland 1
United States|Italy|Japan|Sweden|United Kingdom 1
United States|Spain 1

Sites per Study

Site_count Study_Count
1 45
2 6
3 3
4 3
5 1
6 1
8 1
10 2
11 2
13 1
15 1
17 2
20 2
22 3
24 1
31 1
32 1
33 1
38 1
46 1
49 1
52 1
91 1
98 1

Phase

Phase Study_Count
Phase 2 25
N/A 20
Phase 3 19
Phase 4 8
Phase 2/Phase 3 7
Phase 1 3
Phase 1/Phase 2 1

Number of Arms

Number_of_Arms Count_of_Studies
1 15
2 41
3 7
4 6
5 1
9 1
NA 12

Enrollment Metrics by Phase

Measure N.A Phase.1 Phase.1.Phase.2 Phase.2 Phase.2.Phase.3 Phase.3 Phase.4
Min. 15.0 15.0 17 8.00 33.0000 8.0000 30.00
1st Qu. 29.5 21.5 17 33.00 107.0000 50.0000 45.25
Median 74.0 28.0 17 77.00 130.0000 117.0000 58.00
Mean 100.4 49.0 17 112.25 218.5714 166.2632 165.00
3rd Qu. 145.0 66.0 17 141.50 176.5000 204.0000 188.25
Max. 400.0 104.0 17 420.00 800.0000 569.0000 568.00

Trial Group Type

group_type Group_Count
Experimental 79
Active Comparator 35
Placebo Comparator 32
NA 12
No Intervention 5
Other 5

Intervention Model

intervention_model Study_Count
Parallel Assignment 55
Single Group Assignment 17
Crossover Assignment 8
NA 3

Primary Purpose

primary_purpose Study_Count
Treatment 68
Prevention 5
Basic Science 3
Diagnostic 2
NA 2
Other 1
Screening 1
Supportive Care 1

Observational Studies

Studies by Country

Country Study_Count
Germany 5
United States 4
Denmark 3
Italy 3
France 2
NA 2
Austria 1
Austria|Germany|Switzerland 1
Austria|Hungary|North Macedonia|Poland|Serbia|Spain 1
Canada 1
Denmark|Germany 1
Egypt 1
Germany|India 1
Korea, Republic of 1
Taiwan 1
United States|Australia|Canada|United Kingdom 1

Sites per Study

Site_count Study_Count
1 19
2 2
5 2
7 1
10 2
11 1
14 1
76 1

Enrollment Metrics

Measure Observational
Min 1.000
1st Qu 39.000
Median 115.000
Mean 1061.207
3rd Qu 490.000
Max 20000.000

Observation Model

observational_model Study_Count
Cohort 16
Case-Control 8
Case Control 3
Other 2

Time Perspective

time_perspective Study_Count
Prospective 21
Cross-Sectional 6
Retrospective 2

Registries

Studies by Country

Country Study_Count
Egypt 1
Norway 1
Spain 1
United States 1
United States|Australia 1

Sites per Study

Site_count Study_Count
1 3
2 1
5 1

Enrollment Metrics

Measure Registries
Min 200
1st Qu 200
Median 2000
Mean 5480
3rd Qu 5000
Max 20000

Registry Model

observational_model Study_Count
Case-Only 2
Cohort 2
Case-Control 1

Time Perspective

time_perspective Study_Count
Prospective 4
Cross-Sectional 1

Follow-up

target_duration Study_Count
1 Day 1
10 Years 1
100 Years 1
3 Years 1
5 Years 1

Overview of Studies

Interventional Trials

#If less then 500 trials

nct_id brief_title link overall_status source primary_completion_date
NCT04322240 Alpha Lipoic Acid and Diabetes Mellitus: Potential Effects on Peripheral Neuropathy https://ClinicalTrials.gov/show/NCT04322240 Recruiting Benha University 2020-07-15
NCT03252132 Resistance Training in Patients With Diabetic Neuropathy https://ClinicalTrials.gov/show/NCT03252132 Recruiting Danish Pain Research Center 2018-12-31
NCT03050827 Muscarinic Receptor Antagonists as a Therapy for Diabetic Neuropathy https://ClinicalTrials.gov/show/NCT03050827 Completed Eastern Virginia Medical School 2017-08-17
NCT03008733 Descriptive Analysis of Morphological Aspects of Nerve by Ultra-high Frequency Ultrasound (30-50MHZ) in Demyelinating Neuropathies: Inflammatory Demyelinating Polyneuropathy Chronic (IPDC), Neuropathy Multifocal Motor Block of Conducting (NMMBC) and Neuropathy With Antibody A MAG https://ClinicalTrials.gov/show/NCT03008733 Recruiting Centre Hospitalier Universitaire de Nice 2018-12-31
NCT02871284 Prevention of Chemotherapy-Related Polyneuropathy Via Sensorimotor Exercise Training https://ClinicalTrials.gov/show/NCT02871284 Completed German Cancer Research Center 2019-07-31
NCT02595983 The Study of an Investigational Drug, Revusiran (ALN-TTRSC), for the Treatment of Transthyretin (TTR)-Mediated Amyloidosis in Patients Whose Disease Has Continued to Worsen Following Liver Transplant https://ClinicalTrials.gov/show/NCT02595983 Completed Alnylam Pharmaceuticals 2017-02-06
NCT02027701 Extension Study of Maintenance Treatment With Subcutaneous Immunoglobulin (IgPro20) for Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) https://ClinicalTrials.gov/show/NCT02027701 Completed CSL Behring 2017-07-10
NCT02341261 Activity for Diabetic Polyneuropathy https://ClinicalTrials.gov/show/NCT02341261 Recruiting Virginia Commonwealth University 2022-04-30
NCT02260388 Patient Assisted Intervention for Neuropathy: Comparison of Treatment in Real Life Situations https://ClinicalTrials.gov/show/NCT02260388 Completed University of Kansas Medical Center 2017-09-30
NCT02191826 Study of SOM0226 in Familial Amyloid Polyneuropathy https://ClinicalTrials.gov/show/NCT02191826 Completed SOM Biotech SL 2015-11-30
NCT02175004 Open-Label Extension Assessing Long Term Safety and Efficacy of IONIS-TTR Rx in Familial Amyloid Polyneuropathy (FAP) https://ClinicalTrials.gov/show/NCT02175004 Active, not recruiting Ionis Pharmaceuticals, Inc. 2022-06-30
NCT02129231 Statins for Oxidative Stress and Mitochondrial Function in Diabetic Polyneuropathy https://ClinicalTrials.gov/show/NCT02129231 Completed University of Guadalajara 2014-01-31
NCT02121678 Effect of Resistance and Aerobic Exercise in CIDP or MMN https://ClinicalTrials.gov/show/NCT02121678 Completed University of Aarhus 2015-12-31
NCT02107469 A Study of Phyllanthus Niruri and Sida Cordifolia in Diabetic Peripheral Polyneuropathy https://ClinicalTrials.gov/show/NCT02107469 Completed Rosenberg European Academy of Ayurveda 2016-02-29
NCT02045199 Efficacy and Safety of V0111 Cream on Open Cracked Heel in Diabetic Patients With Polyneuropathy. https://ClinicalTrials.gov/show/NCT02045199 Completed Pierre Fabre Medicament 2015-03-31
NCT01960348 APOLLO: The Study of an Investigational Drug, Patisiran (ALN-TTR02), for the Treatment of Transthyretin (TTR)-Mediated Amyloidosis https://ClinicalTrials.gov/show/NCT01960348 Completed Alnylam Pharmaceuticals 2017-08-31
NCT01926522 Technological Rehabilitation of Distal Sensorimotor Polyneuropathy in Diabetic Patients https://ClinicalTrials.gov/show/NCT01926522 Completed Habilita, Ospedale di Sarnico 2013-11-30
NCT01824251 Phase III Clinical Trial of NPB-01maintenance Therapy in Patients With Chronic Inflammatory Demyelinating Polyneuropathy. https://ClinicalTrials.gov/show/NCT01824251 Completed Nihon Pharmaceutical Co., Ltd 2015-09-30
NCT01737398 Efficacy and Safety of Inotersen in Familial Amyloid Polyneuropathy https://ClinicalTrials.gov/show/NCT01737398 Completed Ionis Pharmaceuticals, Inc. 2017-03-03
NCT01713426 A Study to Compare QUTENZA With Pregabalin for the Treatment of Peripheral Neuropathic Pain (PNP) After 8 Weeks of Treatment https://ClinicalTrials.gov/show/NCT01713426 Completed Astellas Pharma Inc 2013-09-26
NCT01622777 The Effect of Rosuvastatin in Diabetic Polyneuropathy: A Phase IIa Randomized Double-blind Placebo-controlled Study https://ClinicalTrials.gov/show/NCT01622777 Completed University of Guadalajara 2011-01-31
NCT01607684 Pilot Study to Evaluate Magnetic Marker Imaging on Diabetic Polyneuropathy and Gastroparesis https://ClinicalTrials.gov/show/NCT01607684 Completed Martin-Luther-Universität Halle-Wittenberg 2012-09-30
NCT01565317 Evaluating the Effect of Diabetes Control Through Intensive Lifestyle Modifications on Diabetic Peripheral Neuropathy https://ClinicalTrials.gov/show/NCT01565317 Completed Joslin Diabetes Center 2015-05-31
NCT01545076 Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) and Treatment With Subcutaneous Immunoglobulin (IgPro20) https://ClinicalTrials.gov/show/NCT01545076 Completed CSL Behring 2016-09-30
NCT01465620 Dietetic and Hygiene Measures in Metabolic Neuropathies: the Neurodiet Study https://ClinicalTrials.gov/show/NCT01465620 Completed Henri Mondor University Hospital 2018-06-30
NCT01450163 Evaluate The Efficacy and Safety Of Pregabalin In Prevention, Reduction of Oxaliplatin-Induced Painful Neuropathy https://ClinicalTrials.gov/show/NCT01450163 Completed University of Sao Paulo 2014-10-31
NCT01435655 The Effect Of Tafamidis For The Transthyretin Amyloid Polyneuropathy Patients With V30M Or Non-V30M Transthyretin https://ClinicalTrials.gov/show/NCT01435655 Completed Pfizer 2014-02-28
NCT01370837 Neurogenic Inflammation in Diabetes https://ClinicalTrials.gov/show/NCT01370837 Completed Maastricht University Medical Center 2015-01-31
NCT01349270 Randomized Open-label Trial to Compare Efficacy and Tolerance of Corticosteroids and IVIg https://ClinicalTrials.gov/show/NCT01349270 Completed Centre Hospitalier Universitaire de Saint Etienne 2013-12-31
NCT01347671 Safety and Efficacy of GRT6005 in Pain Due to Diabetic Polyneuropathy https://ClinicalTrials.gov/show/NCT01347671 Completed Grünenthal GmbH 2012-01-31
NCT04214665 To Assess the Bioequivalence of Test Oral Formulation of Alpha Lipoic Acid 600 mg HR Film Coated Tablets of Ilko Ilac San. Ve Tic. A.S. Versus Reference Thioctacid (Alpha Lipoic Acid) 600 mg HR Film Coated Tablets of Meda Pharma GmbH& CO .KG, Germany. https://ClinicalTrials.gov/show/NCT04214665 Completed Ilko Ilac San. ve Tic. A.S. 2015-01-24
NCT04136184 NEURO-TTRansform: A Study to Evaluate the Efficacy and Safety of AKCEA-TTR-LRx in Participants With Hereditary Transthyretin-Mediated Amyloid Polyneuropathy https://ClinicalTrials.gov/show/NCT04136184 Recruiting Ionis Pharmaceuticals, Inc. 2024-01-31
NCT03765489 Electrical Muscle Stimulation in the Development of Acquired Weakness in Patients With Severe Sepsis and Septic Shock https://ClinicalTrials.gov/show/NCT03765489 Completed University of Chile 2018-06-21
NCT03687840 Spatio-Temporal Gait Parameters and Gait Symmetry In Diabetic Lower Extremity Burn Injury. https://ClinicalTrials.gov/show/NCT03687840 Completed Recep Tayyip Erdogan University Training and Research Hospital 2018-02-11
NCT03684018 Single vs. Multiple Privigen Dose Regimens in Pediatric CIDP https://ClinicalTrials.gov/show/NCT03684018 Active, not recruiting CSL Behring 2022-08-31
NCT03617185 Effect of Exercise and Surgical Weight Loss on Polyneuropathy https://ClinicalTrials.gov/show/NCT03617185 Recruiting University of Michigan 2023-01-01
NCT01263132 Neuropathic Pain Management https://ClinicalTrials.gov/show/NCT01263132 Completed Merck KGaA, Darmstadt, Germany 2010-02-28
NCT01184846 Study of Efficacy and Safety of Privigen in Subjects With Chronic Inflammatory Demyelinating Polyneuropathy https://ClinicalTrials.gov/show/NCT01184846 Completed CSL Behring 2011-11-30
NCT01079325 Clinical Trial of SB-509 in Subjects With Diabetic Neuropathy https://ClinicalTrials.gov/show/NCT01079325 Completed Sangamo Therapeutics 2015-05-31
NCT01076478 Asian Study on Cilostazol Effectivity in Neuropathies of Diabetes Mellitus Type 2-A Pilot Study in the Philippines https://ClinicalTrials.gov/show/NCT01076478 Completed Otsuka Pharmaceutical, Inc., Philippines NA
NCT01006915 Surgical Decompression for Diabetic Neuropathy in the Foot https://ClinicalTrials.gov/show/NCT01006915 Completed Timothy J. Best Medicine Professional Corporation 2015-03-31
NCT00993070 Efficacy and Safety Study of Topical Capsaicin in Painful Diabetic Neuropathy https://ClinicalTrials.gov/show/NCT00993070 Completed Thammasat University 2011-12-31
NCT00977483 Assessment of Efficacy and Safety of Thioctic Acid in the Oral Treatment of Diabetic Polyneuropathy (Stage 1 or 2) https://ClinicalTrials.gov/show/NCT00977483 Completed MEDA Pharma GmbH & Co. KG 2005-01-31
NCT00962429 Lipoic Acid to Treat Chronic Inflammatory Demyelinating Polyneuropathy https://ClinicalTrials.gov/show/NCT00962429 Completed Oregon Health and Science University 2013-01-31
NCT00944697 A Study to Demonstrate the Analgesic Efficacy of Oxycodone/Naloxone Prolonged Release Tablets in Addition to Pregabalin Compared to Pregabalin Alone in Opioid-naïve Subjects Treated With Pregabalin Suffering From Moderate to Severe Pain Due to Diabetic Polyneuropathy https://ClinicalTrials.gov/show/NCT00944697 Completed Mundipharma Research GmbH & Co KG 2010-03-31
NCT00927914 Evaluating the Efficacy and Safety of Oral Ranirestat (40 and 80 mg) in Mild to Moderate Diabetic Sensorimotor Polyneuropathy https://ClinicalTrials.gov/show/NCT00927914 Completed Eisai Inc. 2013-01-31
NCT03870295 Technique to Measure Type C Fibre Nerve Conduction Velocitynerve Fibers in Polyneuropathies https://ClinicalTrials.gov/show/NCT03870295 Recruiting Centre Hospitalier Intercommunal de Toulon La Seyne sur Mer 2020-09-29
NCT00878293 Painful Diabetic Polyneuropathy Trial With a New Centrally Acting Analgesic https://ClinicalTrials.gov/show/NCT00878293 Completed Grünenthal GmbH 2010-05-31
NCT01302275 Oxcarbazepine for the Treatment of Chronic Peripheral Neuropathic Pain https://ClinicalTrials.gov/show/NCT01302275 Completed Odense University Hospital 2013-05-31
NCT00802022 Effect of Spinal Cord Stimulation in Painful Diabetic Polyneuropathy https://ClinicalTrials.gov/show/NCT00802022 Completed Maastricht University Medical Center 2010-07-31
NCT04281472 A Study to Assess the Safety and Efficacy of a Subcutaneous Formulation of Efgartigimod in Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP, an Autoimmune Disorder That Affects the Peripheral Nerves) https://ClinicalTrials.gov/show/NCT04281472 Recruiting argenx BVBA 2023-08-15
NCT00791492 An Extension of Study Fx-005 Evaluating Long-Term Safety And Clinical Outcomes Of Fx-1006A In Patients With Transthyretin Amyloid Polyneuropathy https://ClinicalTrials.gov/show/NCT00791492 Completed Pfizer 2008-08-31
NCT00759265 Improving Mobility in Diabetic Patients Through Resistance Training https://ClinicalTrials.gov/show/NCT00759265 Completed Maastricht University Medical Center 2010-02-28
NCT00716066 Autologous Peripheral Blood Stem Cell Transplant for Neurologic Autoimmune Diseases https://ClinicalTrials.gov/show/NCT00716066 Recruiting Fred Hutchinson Cancer Research Center 2026-03-31
NCT00665145 Stem Cell Mobilization in Diabetic Neuropathy Subjects Receiving SB-509 https://ClinicalTrials.gov/show/NCT00665145 Completed Sangamo Therapeutics 2009-10-31
NCT00630864 The Effects of Fx-1006A on Transthyretin Stabilization and Clinical Outcome Measures in Patients With Non-V30M Transthyretin Amyloidosis https://ClinicalTrials.gov/show/NCT00630864 Completed Pfizer 2010-01-31
NCT00614562 Neurally Adjusted Ventilatory Assist (NAVA) in Patients With Critical Illness Associated Polyneuropathy / or Polymyopathy (CIP/M) https://ClinicalTrials.gov/show/NCT00614562 Completed University Hospital Inselspital, Berne 2009-06-30
NCT01251211 Botulinum Toxin in Peripheral Neuropathic Pain https://ClinicalTrials.gov/show/NCT01251211 Completed Hospital Ambroise Paré Paris 2014-01-31
NCT00570310 Neuropathic Pain Syndrome Patient Study (MK-0000-072) https://ClinicalTrials.gov/show/NCT00570310 Completed Merck Sharp & Dohme Corp. 2008-09-30
NCT00539175 Treatment of Painful Diabetic Neuropathy With Photon Stimulation https://ClinicalTrials.gov/show/NCT00539175 Completed East Bay Institute for Research and Education NA
NCT00507936 Safety and Efficacy Study in Subjects With Diabetic Neuropathic Pain https://ClinicalTrials.gov/show/NCT00507936 Completed AbbVie 2008-10-31
NCT00501202 Study for Safety and Effectiveness of RWJ-333369 (Carsibamate) for the Treatment of Diabetic Peripheral Neuropathy (DPN). https://ClinicalTrials.gov/show/NCT00501202 Completed SK Life Science, Inc. 2008-05-31
NCT00483730 Actovegin® Versus Placebo in Patients With Diabetic Polyneuropathy (AV-007-IM) https://ClinicalTrials.gov/show/NCT00483730 Completed Nycomed 2008-05-31
NCT00476931 Clinical Trial of SB-509 in Subjects With Diabetic Neuropathy https://ClinicalTrials.gov/show/NCT00476931 Completed Sangamo Therapeutics 2010-07-31
NCT00409175 Safety and Efficacy Study of Fx-1006A in Patients With Familial Amyloidosis https://ClinicalTrials.gov/show/NCT00409175 Completed Pfizer 2009-05-31
NCT00406458 Clinical Trial of SB-509 in Subjects With Diabetic Neuropathy https://ClinicalTrials.gov/show/NCT00406458 Completed Sangamo Therapeutics 2008-12-31
NCT00328601 Assessment of Efficacy and Safety of Thioctic Acid in the Oral Treatment of Symptomatic Diabetic Neuropathy (SYDNEY 2) https://ClinicalTrials.gov/show/NCT00328601 Completed MEDA Pharma GmbH & Co. KG NA
NCT00307749 Safety and Efficacy of MCC-257 in the Treatment of Diabetic Polyneuropathy https://ClinicalTrials.gov/show/NCT00307749 Completed Mitsubishi Tanabe Pharma Corporation NA
NCT00294671 The Effect of Diflunisal on Familial Amyloidosis https://ClinicalTrials.gov/show/NCT00294671 Completed Boston University 2012-12-31
NCT00289497 TempTouch IR Thermometry & Diabetic Patient Self-Care https://ClinicalTrials.gov/show/NCT00289497 Completed Diabetica Solutions Inc. NA
NCT00286260 Levetiracetam for Painful Polyneuropathy https://ClinicalTrials.gov/show/NCT00286260 Completed Odense University Hospital 2008-08-31
NCT00278980 Effect of C-Peptide on Diabetic Peripheral Neuropathy https://ClinicalTrials.gov/show/NCT00278980 Completed Creative Peptides Sweden Inc. NA
NCT00278629 Hematopoietic Stem Cell Transplantation in Chronic Inflammatory Demyelinating Polyneuropathy https://ClinicalTrials.gov/show/NCT00278629 Active, not recruiting Northwestern University 2019-07-31
NCT00259974 RIMAG Study: Trial of Rituximab Versus Placebo in Polyneuropathy Associated With Anti-MAG IgM Monoclonal Gammopathy https://ClinicalTrials.gov/show/NCT00259974 Completed Assistance Publique - Hôpitaux de Paris 2010-01-31
NCT00231673 A Study To Evaluate The Effect Of Topiramate On Clinical And Electrophysiological Parameters In Subjects With Diabetic Peripheral Polyneuropathy https://ClinicalTrials.gov/show/NCT00231673 Completed Johnson & Johnson Pharmaceutical Research & Development, L.L.C. NA
NCT00220740 Immune Globulin Intravenous (IGIV) For Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) https://ClinicalTrials.gov/show/NCT00220740 Completed Grifols Therapeutics LLC 2006-06-30
NCT00162968 Escitalopram as a Treatment for Pain in Polyneuropathy https://ClinicalTrials.gov/show/NCT00162968 Completed Odense University Hospital NA
NCT00156689 A Study to Determine if Levetiracetam Will Assist Those Suffering From Chronic Idiopathic Axonal Polyneuropathy. https://ClinicalTrials.gov/show/NCT00156689 Completed Vanderbilt University NA
NCT00105755 Dermal Thermometry and Self-Care of High Risk Diabetic Patients https://ClinicalTrials.gov/show/NCT00105755 Completed VA Office of Research and Development NA
NCT00101426 Safety and Efficacy of AS-3201 in the Treatment of Diabetic Sensorimotor Polyneuropathy https://ClinicalTrials.gov/show/NCT00101426 Completed Sumitomo Dainippon Pharma Co., Ltd. NA
NCT00082316 Tolerability of Three Local Anesthetic Formulations in Conjunction With NGX-4010 for the Treatment of Neuropathic Pain https://ClinicalTrials.gov/show/NCT00082316 Completed NeurogesX NA
NCT00001287 Intravenous Immunoglobulin (IVIg) for the Treatment of Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) https://ClinicalTrials.gov/show/NCT00001287 Completed National Institutes of Health Clinical Center (CC) NA
NCT00050245 Rituximab to Treat Neuropathy With Anti-MAG Antibodies https://ClinicalTrials.gov/show/NCT00050245 Completed National Institutes of Health Clinical Center (CC) NA

Observational Studiess

#If less then 500 studies

nct_id brief_title link overall_status source primary_completion_date
NCT03819959 Metabolomics Study on Intensive Care Acquired Muscle Weakness in Polytrauma https://ClinicalTrials.gov/show/NCT03819959 Recruiting Technische Universität München 2021-01-01
NCT02947828 Polyneuropathy in Diabetes Mellitus Type 2 https://ClinicalTrials.gov/show/NCT02947828 Completed Danish Pain Research Center 2018-11-30
NCT02846844 Patients With Chemotherapy-induced Polyneuropathy Are Treated With an Integrated Program Including Massage, Mobilization in Posture and Transport Layers, Physical Exercises or With Whole-body Vibration Platform Training https://ClinicalTrials.gov/show/NCT02846844 Completed University of Ulm 2015-10-31
NCT02753036 Chemotherapy-induced Cognitive Alterations in Recruits With Ovarian and Breast Cancer https://ClinicalTrials.gov/show/NCT02753036 Recruiting Charite University, Berlin, Germany 2019-07-31
NCT02713880 Biomarker for Transthyretin-Related Familial Amyloidotic Polyneuropathy (BioTRAP) https://ClinicalTrials.gov/show/NCT02713880 Completed Centogene AG Rostock 2019-12-01
NCT02706314 Impact of Human Blood Serum From Critically Ill Patients on Human Colon Neuronal Networks. https://ClinicalTrials.gov/show/NCT02706314 Completed University of Rostock 2019-04-16
NCT02588898 B-Vitamins and Polyneuropathy in Patients With Type 2 Diabetes https://ClinicalTrials.gov/show/NCT02588898 Completed Saarland University 2011-01-31
NCT01705626 Screening for the Transthyretin-Related Familial Amyloidotic Polyneuropathy (TTR FAP) https://ClinicalTrials.gov/show/NCT01705626 Recruiting Centogene AG Rostock 2020-12-31
NCT02442986 Neurological Outcome in Surgical and Non-surgical Septic Patients https://ClinicalTrials.gov/show/NCT02442986 Completed University of Rostock 2017-03-31
NCT02423434 Evaluation of Corneal Confocal Microscopy for the Identification and Prediction of Neuropathy in Type 1 Diabetes https://ClinicalTrials.gov/show/NCT02423434 Completed Samuel Lunenfeld Research Institute, Mount Sinai Hospital 2018-08-31
NCT02414490 IVIg Treatment-Related Fluctuations in CIDP Patients Using Daily Grip Strength Measurements https://ClinicalTrials.gov/show/NCT02414490 Active, not recruiting University of Minnesota 2019-05-31
NCT02111590 Immunoglobulin Dosage and Administration Form in CIDP and MMN https://ClinicalTrials.gov/show/NCT02111590 Completed Rigshospitalet, Denmark 2015-07-31
NCT01931644 At-Home Research Study for Patients With Autoimmune, Inflammatory, Genetic, Hematological, Infectious, Neurological, CNS, Oncological, Respiratory, Metabolic Conditions https://ClinicalTrials.gov/show/NCT01931644 Recruiting Sanguine Biosciences 2025-08-31
NCT01847937 Magnetic Resonance Diagnostics of Diabetic Peripheral Neuropathy https://ClinicalTrials.gov/show/NCT01847937 Completed Aarhus University Hospital 2016-09-30
NCT01604122 Burden of Disease Study In Patients With Transthyretin Familial Amyloidosis Polyneuropathy (TTR-FAP) orTransthyretin Cardiomyopathy (TTR-CM) And Caregivers https://ClinicalTrials.gov/show/NCT01604122 Completed Pfizer 2015-07-27
NCT01488474 Peripheral Nerve Stimulation in Diabetic Patients https://ClinicalTrials.gov/show/NCT01488474 Completed Medical University of Graz 2013-12-31
NCT01379833 Prevalence of Decreased Corneal Sensation in Patients With Chronic Inflammatory Demyelinating Polyneuropathy https://ClinicalTrials.gov/show/NCT01379833 Completed State University of New York at Buffalo 2013-12-31
NCT04201418 A Multicenter Observational Study to Evaluate the Effectiveness of Patisiran in Patients With Polyneuropathy of hATTR Amyloidosis With a V122I or T60A Mutation https://ClinicalTrials.gov/show/NCT04201418 Recruiting Alnylam Pharmaceuticals 2022-06-30
NCT04193943 Validation of Simplified Electrophysiological Examination in the Diagnosis of Critical Illness Myopathy or Neuropathy https://ClinicalTrials.gov/show/NCT04193943 Active, not recruiting Università degli Studi di Brescia 2014-11-26
NCT03934970 Diffusion Tensor Imaging of Median Nerve in Diabetic Peripheral Neuropathy https://ClinicalTrials.gov/show/NCT03934970 Completed Cairo University 2015-11-30
NCT03893058 Evaluation of the NeuroMuscular Junction Using the Single Fiber Electromyography and Reliability of Train-Of-Four in Critically Ill Patients. https://ClinicalTrials.gov/show/NCT03893058 Recruiting Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia 2020-12-31
NCT03779828 Evaluating the Effectiveness of Telemonitoring System in the Management of Patients With CIDP https://ClinicalTrials.gov/show/NCT03779828 Completed CSL Behring 2019-06-03
NCT01261442 Can Ultrasound Detect Diabetic Peripheral Neuropathy? https://ClinicalTrials.gov/show/NCT01261442 Completed University Health Network, Toronto 2012-02-29
NCT01094418 Electrodiagnostic Parameters in Patients With Impaired Glucose Tolerance and Diabetes Mellitus https://ClinicalTrials.gov/show/NCT01094418 Completed The Catholic University of Korea 2010-02-28
NCT04208295 24-hour Blood Pressure Dynamics and Autonomic Adrenergic Regulation in Type 2 Diabetics https://ClinicalTrials.gov/show/NCT04208295 Enrolling by invitation University of Aarhus 2020-06-30
NCT04119167 Use of GDF15 as a Biomarker for Early Diagnosis of DM and Monitoring of Progress of Complications in Asians https://ClinicalTrials.gov/show/NCT04119167 Recruiting Chang Gung Memorial Hospital 2021-07-30
NCT03616314 Effects of Early Stepping Verticalization + FES on CIP https://ClinicalTrials.gov/show/NCT03616314 Completed Ospedale Generale Di Zona Moriggia-Pelascini 2018-07-01
NCT03373370 Early Diagnosis of TTR Amyloidosis by Use of Molecular Biology https://ClinicalTrials.gov/show/NCT03373370 Recruiting Assistance Publique - Hôpitaux de Paris 2020-12-27
NCT03237494 Epidemiological Analysis for the Hereditary Transthytetin-related Amyloidosis (hATTR) https://ClinicalTrials.gov/show/NCT03237494 Recruiting Centogene AG Rostock 2020-12-31

Registries

#If less then 500 registries

nct_id brief_title link overall_status source primary_completion_date
NCT02985294 Peripheral Physiological Measures as Determinants of Pain Risk https://ClinicalTrials.gov/show/NCT02985294 Recruiting Neuroscience Technologies SLP, Barcelona 2019-03-31
NCT02124616 National Registry for Egyptian Pediatric Neuromuscular Diseases https://ClinicalTrials.gov/show/NCT02124616 Recruiting Ain Shams University 2020-04-30
NCT01793168 Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford https://ClinicalTrials.gov/show/NCT01793168 Recruiting Sanford Health 2100-12-31
NCT03862365 Exploring the Genetics of Neuropathic Pain https://ClinicalTrials.gov/show/NCT03862365 Recruiting Oslo University Hospital 2027-01-01
NCT03717844 Registry for Adults With Plasma Cell Disorders (PCD’s) https://ClinicalTrials.gov/show/NCT03717844 Recruiting UNC Lineberger Comprehensive Cancer Center 2028-02-29